Episurf Medical AB (publ) (STO:EPIS.B)
Sweden · Delayed Price · Currency is SEK 0.0745
-0.0021 (-2.74%)
Sep 4, 2026, 5:29 PM CET
Episurf Medical AB Cash Flow Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -86.6 | -58.2 | -76 | -94.8 | -77.3 | -69.3 |
Depreciation & Amortization | 6.2 | 5.6 | 6 | 6 | 5.1 | 5.3 |
Other Amortization | 3.1 | 2.5 | 3 | 2.7 | 2.3 | 2.1 |
Stock-Based Compensation | 0.3 | 0.3 | 1 | 0.7 | -0.2 | 3.3 |
Other Operating Activities | 0.7 | 0.6 | - | -0.2 | -0.3 | -0.3 |
Change in Accounts Receivable | -1.4 | -2.8 | -0.8 | 0.4 | -0.3 | -1 |
Change in Inventory | 0.8 | 0.2 | 0.5 | -1.8 | 0.1 | - |
Change in Other Net Operating Assets | -17.8 | -3.5 | -5.1 | 2.2 | 1.1 | 0.2 |
Operating Cash Flow | -45.4 | -55.3 | -71.4 | -84.8 | -69.5 | -59.7 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -0.2 | - | - | - | - | -0.1 |
Sale (Purchase) of Intangibles | -7.8 | -6.7 | -7.6 | -9.5 | -11.3 | -6.9 |
Investment in Securities | - | - | - | - | - | 0.5 |
Other Investing Activities | - | - | - | - | 0.1 | - |
Investing Cash Flow | -11.2 | -6.7 | -7.6 | -9.5 | -11.2 | -6.5 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt Issued | 44.1 | - | - | - | - | - |
Long-Term Debt Repaid | - | -3.6 | -2.4 | -3.2 | -2.4 | -2.4 |
Lease Payments | -4.6 | -3.6 | -2.4 | -3.2 | -2.4 | -2.4 |
Net Debt Issued (Repaid) | -4 | -3.6 | -2.4 | -3.2 | -2.4 | -2.4 |
Issuance of Common Stock | 43.2 | 29.7 | 90.2 | 0.2 | 0.5 | 159.6 |
Other Financing Activities | -17.2 | -7.5 | -16.2 | - | - | -8 |
Financing Cash Flow | 22 | 18.6 | 71.6 | -3 | -1.9 | 149.2 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Miscellaneous Cash Flow Adjustments | 0.1 | - | - | -0.1 | - | - |
Net Cash Flow | -34.5 | -43.4 | -7.4 | -97.4 | -82.6 | 83 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -45.6 | -55.3 | -71.4 | -84.8 | -69.5 | -59.8 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -174.71% | -273.76% | -346.60% | -428.28% | -1053.03% | -920.00% |
Free Cash Flow Per Share | -0.04 | -0.06 | -0.15 | -0.27 | -0.26 | -0.26 |
Levered Free Cash Flow | 33.28 | -40.4 | -51.48 | -60.26 | -51.76 | -40.46 |
Unlevered Free Cash Flow | 36.71 | -40.03 | -50.85 | -59.7 | -51.33 | -40.34 |
Free Cash Flow After Leases | -50.2 | -58.9 | -73.8 | -88 | -71.9 | -62.2 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 5.2 | 0.3 | 1 | 0.6 | 0.6 | 0.2 |
Change in Working Capital | 30.9 | -6.1 | -5.4 | 0.8 | 0.9 | -0.8 |